Search
Returning search results with filters:
Remove filter for
Last updated: 2021
Remove filter for
Type: Health professional risk communication
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 16 - 25 of 25 items.
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia
AlertHealth professional risk communication | 2021-03-24
Pfizer-BioNTech COVID-19 Vaccine: Updated Storage and Transportation Conditions
AlertHealth professional risk communication | 2021-03-08
Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-08
Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-01
Authorization of COVISHIELD with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-01
COVID-19 Vaccine Moderna: Updated English-only Global Vial and Carton Labels and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-22
Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-09
GILENYA (fingolimod) - Risk of Liver Injury
AlertHealth professional risk communication | 2021-01-18
Important Safety Information on SUBOXONE (buprenorphine and naloxone) and the Risk of Overdose or Underdose when Switching Between Dosage Forms or Routes of Administration
AlertHealth professional risk communication | 2021-01-07
Importation of German-labelled Hydromorphon Ethypharm Kalceks (Hydromorphone Hydrochloride Solution for Injection) due to Potential Shortage of Canadian-labelled HYDROmorphone
AlertHealth professional risk communication | 2021-01-06